Showing results (411-420 of 474) with videos related to

Sort By:
Pageof 48
Hepatology (Baltimore, Md.)|May 22, 2022
Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablationXuezhen Zeng, Guanrui Liao, Shumin Li, et al.
Life Sciences|July 11, 2018
Multiparametric radiomics improve prediction of lymph node metastasis of rectal cancer compared with conventional radiomicsLi-Da Chen, Jin-Yu Liang, Hui Wu, et al.
Academic Radiology|July 6, 2020
Preoperative Pathological Grading of Hepatocellular Carcinoma Using Ultrasomics of Contrast-Enhanced UltrasoundWei Wang, Shan-Shan Wu, Jian-Chao Zhang, et al.
Signal Transduction and Targeted Therapy|April 18, 2022
c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responsesXu-Yan Wang, Yuan Wei, Bo Hu, et al.
JHEP Reports : Innovation in Hepatology|May 21, 2026
Combining MRI criterion and pathology-based microvascular invasion improves prognostic stratification in early HCCXinyuan Jia, Junhan Pan, Yanshu Wang, et al.
Annals of Surgical Oncology|March 22, 2021
Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling ProtocolLili Chen, Shuling Chen, Qian Zhou, et al.
Gastroenterology|December 8, 2023
Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal CancerLei Sun, Ruonian Liu, Zong-Jian Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic CholangiocarcinomaShuling Chen, Yubin Xie, Yuhong Cai, et al.
Nature Communications|December 8, 2025
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinomaXin Liu, Zelong Liu, Chengzhan Zhu, et al.
Immunity|December 23, 2022
Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinomaRui-Qi Wu, Xiang-Ming Lao, Dong-Ping Chen, et al.
Pageof 48